Half dose of prostate drugs ‘controls cancer without severe side effects’

Sănătate

12 March 2026 A major UK clinical trial co-led by Professor Allan Hackshaw (UCL Cancer Institute) will test whether lower doses of common hormone therapies can treat advanced prostate cancer while reducing the severe side effects many patients experience. Read: The Times (£) , More: Cancer Research UK , UCL News

din zilele anterioare